Table of Content
1 Market Overview
1.1 Hereditary Angioedema Drug Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Hereditary Angioedema Drug Market Size & Forecast
1.4.1 Global Hereditary Angioedema Drug Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Hereditary Angioedema Drug Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Hereditary Angioedema Drug Market Drivers
1.5.2 Hereditary Angioedema Drug Market Restraints
1.5.3 Hereditary Angioedema Drug Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Pharming Group NV
2.1.1 Business Overview
2.1.2 Pharming Group NV SWOT Analysis
2.1.3 Pharming Group NV Hereditary Angioedema Drug Products and Service Offered
2.1.4 Pharming Group NV Hereditary Angioedema Drug Revenue and Gross Margin
2.2 Shire plc
2.2.1 Business Overview
2.2.2 Shire plc SWOT Analysis
2.2.3 Shire plc Hereditary Angioedema Drug Products and Service Offered
2.2.4 Shire plc Hereditary Angioedema Drug Revenue and Gross Margin
2.3 CSL Limited
2.3.1 Business Overview
2.3.2 CSL Limited SWOT Analysis
2.3.3 CSL Limited Hereditary Angioedema Drug Products and Service Offered
2.3.4 CSL Limited Hereditary Angioedema Drug Revenue and Gross Margin
2.4 iBio Inc.
2.4.1 Business Overview
2.4.2 iBio Inc. SWOT Analysis
2.4.3 iBio Inc. Hereditary Angioedema Drug Products and Service Offered
2.4.4 iBio Inc. Hereditary Angioedema Drug Revenue and Gross Margin
2.5 BioCryst Pharmaceuticals Inc.
2.5.1 Business Overview
2.5.2 BioCryst Pharmaceuticals Inc. SWOT Analysis
2.5.3 BioCryst Pharmaceuticals Inc. Hereditary Angioedema Drug Products and Service Offered
2.5.4 BioCryst Pharmaceuticals Inc. Hereditary Angioedema Drug Revenue and Gross Margin
2.6 Ionis Pharmaceuticals Inc.
2.6.1 Business Overview
2.6.2 Ionis Pharmaceuticals Inc. SWOT Analysis
2.6.3 Ionis Pharmaceuticals Inc. Hereditary Angioedema Drug Products and Service Offered
2.6.4 Ionis Pharmaceuticals Inc. Hereditary Angioedema Drug Revenue and Gross Margin
3 Global Hereditary Angioedema Drug Market Competition, by Manufacturer
3.1 Global Hereditary Angioedema Drug Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Hereditary Angioedema Drug Players Market Share in 2023
3.2.2 Top 6 Hereditary Angioedema Drug Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Hereditary Angioedema Drug Players Head Office, Business Provided
3.4 Hereditary Angioedema Drug Mergers & Acquisitions
3.5 Hereditary Angioedema Drug New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Hereditary Angioedema Drug Revenue in Value by Type (2019-2030)
4.2 Global Hereditary Angioedema Drug Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Hereditary Angioedema Drug Revenue by Application (2019-2030)
5.2 Global Hereditary Angioedema Drug Revenue Share by Application (2019-2030)
6 Global Hereditary Angioedema Drug Market Analysis by Regions
6.1 Global Hereditary Angioedema Drug Revenue and Market Share by Regions
6.1.1 Global Hereditary Angioedema Drug Revenue by Regions (2019-2030)
6.1.2 Global Hereditary Angioedema Drug Revenue Market Share by Regions (2019-2030)
6.2 North America Hereditary Angioedema Drug Revenue and Growth (2019-2030)
6.3 Europe Hereditary Angioedema Drug Revenue and Growth (2019-2030)
6.4 Asia Pacific Hereditary Angioedema Drug Revenue and Growth (2019-2030)
6.5 South America Hereditary Angioedema Drug Revenue and Growth (2019-2030)
6.6 Middle East and Africa Hereditary Angioedema Drug Revenue and Growth (2019-2030)
7 North America Hereditary Angioedema Drug by Country, by Type, and by Application
7.1 North America Hereditary Angioedema Drug Revenue by Type (2019-2030)
7.2 North America Hereditary Angioedema Drug Revenue by Application (2019-2030)
7.3 North America Hereditary Angioedema Drug Revenue and Market Share by Countries
7.3.1 North America Hereditary Angioedema Drug Revenue in Value by Country (2019-2030)
7.3.2 United States Hereditary Angioedema Drug Revenue and Growth (2019-2030)
7.3.3 Canada Hereditary Angioedema Drug Revenue and Growth (2019-2030)
7.3.4 Mexico Hereditary Angioedema Drug Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Hereditary Angioedema Drug by Country, by Type, and by Application
8.1 Europe Hereditary Angioedema Drug Revenue by Type (2019-2030)
8.2 Europe Hereditary Angioedema Drug Revenue by Application (2019-2030)
8.3 Europe Hereditary Angioedema Drug Revenue and Market Share by Countries
8.3.1 Europe Hereditary Angioedema Drug Revenue in Value by Country (2019-2030)
8.3.2 Germany Hereditary Angioedema Drug Revenue and Growth (2019-2030)
8.3.3 France Hereditary Angioedema Drug Revenue and Growth (2019-2030)
8.3.4 United Kingdom Hereditary Angioedema Drug Revenue and Growth (2019-2030)
8.3.5 Russia Hereditary Angioedema Drug Revenue and Growth (2019-2030)
8.3.6 Italy Hereditary Angioedema Drug Revenue and Growth (2019-2030)
8.3.7 Nordic Hereditary Angioedema Drug Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Hereditary Angioedema Drug by Country, by Type, and by Application
9.1 Asia Pacific Hereditary Angioedema Drug Revenue by Type (2019-2030)
9.2 Asia Pacific Hereditary Angioedema Drug Revenue by Application (2019-2030)
9.3 Asia Pacific Hereditary Angioedema Drug Revenue and Market Share by Countries
9.3.1 Asia Pacific Hereditary Angioedema Drug Revenue in Value by Country (2019-2030)
9.3.2 China Hereditary Angioedema Drug Revenue and Growth (2019-2030)
9.3.3 Japan Hereditary Angioedema Drug Revenue and Growth (2019-2030)
9.3.4 Korea Hereditary Angioedema Drug Revenue and Growth (2019-2030)
9.3.5 India Hereditary Angioedema Drug Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Hereditary Angioedema Drug Revenue and Growth (2019-2030)
9.3.7 Australia Hereditary Angioedema Drug Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Hereditary Angioedema Drug by Country, by Type, and by Application
10.1 South America Hereditary Angioedema Drug Revenue by Type (2019-2030)
10.2 South America Hereditary Angioedema Drug Revenue by Application (2019-2030)
10.3 South America Hereditary Angioedema Drug Revenue and Market Share by Countries
10.3.1 South America Hereditary Angioedema Drug Revenue in Value by Country (2019-2030)
10.3.2 Brazil Hereditary Angioedema Drug Revenue and Growth (2019-2030)
10.3.3 Argentina Hereditary Angioedema Drug Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Hereditary Angioedema Drug by Country, by Type, and by Application
11.1 Middle East & Africa Hereditary Angioedema Drug Revenue by Type (2019-2030)
11.2 Middle East & Africa Hereditary Angioedema Drug Revenue by Application (2019-2030)
11.3 Middle East & Africa Hereditary Angioedema Drug Revenue and Market Share by Countries
11.3.1 Middle East & Africa Hereditary Angioedema Drug Revenue in Value by Country (2019-2030)
11.3.2 Turkey Hereditary Angioedema Drug Revenue and Growth (2019-2030)
11.3.3 Egypt Hereditary Angioedema Drug Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Hereditary Angioedema Drug Revenue and Growth (2019-2030)
11.3.5 UAE Hereditary Angioedema Drug Revenue and Growth (2019-2030)
11.3.6 South Africa Hereditary Angioedema Drug Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Hereditary Angioedema Drug Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Hereditary Angioedema Drug Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer